{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:30:56Z","timestamp":1794263456634,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neuropharm.2020.108437","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T07:16:46Z","timestamp":1607671006000},"page":"108437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice"],"prefix":"10.1016","volume":"185","author":[{"given":"D. Matthew","family":"Walentiny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essie","family":"Komla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a T.","family":"Moisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid I.","family":"Akbarali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Beardsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108437_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","article-title":"Tests and models of nociception and pain in rodents","volume":"211","author":"Barrot","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108437_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00210-007-0146-x","article-title":"The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone","volume":"375","author":"Beattie","year":"2007","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108437_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(78)90351-5","article-title":"The effects of naltrexone on the development of physical dependence on morphine","volume":"50","author":"Bhargava","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108437_bib4","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/0024-3205(82)90467-2","article-title":"Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity","volume":"30","author":"Bianchi","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108437_bib5","article-title":"Antagonism of peripheral opioid receptors by methylnaltrexone does not prevent morphine tolerance in rats","author":"Blomqvist","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2020.108437_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(85)90072-3","article-title":"The use of quaternary narcotic antagonists in opiate research","volume":"24","author":"Brown","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108437_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0006-8993(81)90796-4","article-title":"Opiate antagonists: central sites of action in suppressing water intake of the rat","volume":"221","author":"Brown","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108437_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0028-3908(83)90246-0","article-title":"Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives","volume":"22","author":"Brown","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108437_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","article-title":"[(3)H]Alvimopan binding to the \u03bc opioid receptor: comparative binding kinetics of opioid antagonists","volume":"520","author":"Cassel","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108437_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/dmd.109.031179","article-title":"Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans","volume":"38","author":"Chandrasekaran","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2020.108437_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0091-3057(99)00047-7","article-title":"Drug discrimination in neurobiology","volume":"64","author":"Colpaert","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108437_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nm.4262","article-title":"Loss of mu opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia","volume":"23","author":"Corder","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2020.108437_bib13","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1572-0241.2005.00256.x","article-title":"Narcotic use in patients with Crohn's disease","volume":"100","author":"Cross","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.108437_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00403-018-1809-9","article-title":"Attenuation of serotonin-induced itch by sumatriptan: possible involvement of endogenous opioids","volume":"310","author":"Haddadi","year":"2018","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.neuropharm.2020.108437_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1124\/jpet.119.256941","article-title":"Experimental colitis enhances the rate of antinociceptive tolerance to morphine via peripheral opioid receptors","volume":"370","author":"Komla","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108437_bib16","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/00498258909043176","article-title":"Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans","volume":"19","author":"Kotake","year":"1989","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neuropharm.2020.108437_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn's disease: more than 5 Years of follow-up in the TREAT (TM) registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.108437_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1570-0232(02)00527-5","article-title":"Determination of methylnaltrexone in clinical samples by solid-phase extraction and high-performance liquid chromatography for a pharmacokinetics study","volume":"780","author":"Osinski","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.neuropharm.2020.108437_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jpba.2011.08.016","article-title":"Quantitative determination of methylnaltrexone in human serum using liquid chromatography-tandem mass spectrometry","volume":"56","author":"Oswald","year":"2011","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.neuropharm.2020.108437_bib20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/DDDT.S221278","article-title":"The use of peripheral mu-opioid receptor antagonists (PAMORA) in the management of opioid-induced constipation: an update on their efficacy and safety","volume":"14","author":"Pergolizzi","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuropharm.2020.108437_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/7854_2018_40","article-title":"Drug discrimination: historical origins, important concepts, and principles","volume":"39","author":"Porter","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108437_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0024-3205(82)90355-1","article-title":"Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice","volume":"31","author":"Ramabadran","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108437_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbi.2020.01.017","article-title":"Blood-borne and brain-derived microparticles in morphine-induced anti-nociceptive tolerance","volume":"87","author":"Ruhela","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2020.108437_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(82)90026-7","article-title":"Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists","volume":"78","author":"Russell","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108437_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3565(25)31909-9","article-title":"Hyperalgesic effects of divalent cations and antinociceptive effects of a calcium chelator in naive and morphine-dependent mice","volume":"212","author":"Schmidt","year":"1980","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108437_bib26","doi-asserted-by":"crossref","first-page":"107501","DOI":"10.1016\/j.drugalcdep.2019.06.006","article-title":"Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: comparison with naltrexone","volume":"204","author":"Schwienteck","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108437_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101574","article-title":"Preclinical study in vivo for new pharmacological approaches in inflammatory bowel disease: a systematic review of chronic model of TNBS-induced colitis","volume":"8","author":"Silva","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2020.108437_bib28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/ajg.2014.230","article-title":"The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.108437_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuropharm.2019.02.007","article-title":"Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice","volume":"150","author":"Walentiny","year":"2019","journal-title":"Neuropharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2020.108437_bib30","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/pme.12911","article-title":"Opioid-induced constipation","volume":"16","author":"Webster","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2020.108437_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/JPR.S88203","article-title":"Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain","volume":"8","author":"Webster","year":"2015","journal-title":"J. Pain Res."},{"key":"10.1016\/j.neuropharm.2020.108437_bib32","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/JPR.S160488","article-title":"Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain","volume":"11","author":"Webster","year":"2018","journal-title":"J. Pain Res."},{"key":"10.1016\/j.neuropharm.2020.108437_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","article-title":"Methylnaltrexone for reversal of constipation due to chronic methadone use - a randomized controlled trial","volume":"283","author":"Yuan","year":"2000","journal-title":"Jama-Journal of the American Medical Association"},{"key":"10.1016\/j.neuropharm.2020.108437_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0376-8716(98)00087-8","article-title":"Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine","volume":"52","author":"Yuan","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108437_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/jpet.300.1.118","article-title":"Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial","volume":"300","author":"Yuan","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108437_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-014-3637-8","article-title":"Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers","volume":"232","author":"Zacny","year":"2015","journal-title":"Psychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820305050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820305050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:07:06Z","timestamp":1758438426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820305050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":36,"alternative-id":["S0028390820305050"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108437","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108437"}}